Dr. Hammond has served as a member of our Board of Directors since March 2020. Dr. Hammond is Institute Professor and the Dean of Engineering at the Massachusetts Institute of Technology ( MIT ), where she has been a faculty member since 1995. She served as the Head of the Department of Chemical Engineering at MIT from 2015 through 2023 and as Vice Provost for Faculty/Executive Vice Provost from 2024 to 2026. She is a member of MIT s David H. Koch Institute for Integrative Cancer Research and a founding member of the MIT Institute for Soldier Nanotechnology. She investigates electrostatic polymer systems for targeted nanoparticle drug and gene delivery, and is known for her work on nanoparticles to target cancer, and thin film coatings to release factors that regenerate bone and assist in wound healing. Dr. Hammond was elected into the National Academy of Science in 2019, the National Academy of Engineering in 2017, the National Academy of Medicine in 2016, and the 2013 Class of the American Academy of Arts and Sciences. She is also a member of the National Academy of Inventors. She received the Margaret H. Rousseau Pioneer Award for Lifetime Achievement by a Woman Chemical Engineer, the Benjamin Franklin Medal in Chemistry from the Franklin Institute and the National Medal of Technology and Innovation. She was a member of the Scientific Advisory Board of Moderna Therapeutics from 2017 to 2021, she was the co-founder and member of the Scientific Advisory Board of LayerBio, Inc., and a current member of the Board of Sail Biomedicines, a Flagship company. She is also a member of the board of directors of the MIT Engine, and an advisor for Catalio Capital Management. Dr. Hammond served as a member the President s Council of Advisors on Science and Technology (PCAST) from June 2021 to January 2025. Dr. Hammond holds an M.S. in Chemical Engineering from the Georgia Institute of Technology and a Ph.D. and S.B. in Chemical Engineering from MIT. Dr. Hammond has published over 330 papers and over 20 patent applications. We believe Dr. Hammond is qualified to serve on our Board of Directors based on her scientific background and experience as an internationally recognized expert in the field of chemical engineering and based on her work in the field of cancer research.